Meta-analysis of the Association between HLA-DRB1 Allele and Rheumatoid Arthritis Susceptibility in Asian Populations by Jun, Kyung Ran et al.
INTRODUCTION
Rheumatoid arthritis (RA) is a systemic autoimmune dis-
ease characterized by chronic inflammation of the joints,
which may lead to joint destruction and disability. The pre-
valence of RA is about 1% of the population worldwide, and
genetic factors have been estimated to account for 60% of
the disease risk (1). Genetic variation is believed to be impor-
tant in determining both the susceptibility to and severity
of RA, with the strongest association being observed in the
HLA region, in particular, with HLA-DRB1 alleles (1). The
shared epitope (SE) hypothesis has been proposed to explain
susceptibility to RA, based on the observation that HLA-DR
specificities associated with the disease share a similar amino
acid sequence in the third hypervariable region of the HLA-
DRB1 molecule (2, 3). Many studies have attempted to clar-
ify this relationship, but there has been no definite consen-
sus to date (4). Differences in results may be related to the
ethnic and clinical heterogeneity of the patients studied or
to the relatively small numbers of patients in each study.
Meta-analysis is one way to overcome the problems of small
sample size and inconsistent results. Combining the results
from several studies can achieve greater statistical power. Well-
designed meta-analyses of Caucasian and Native American
populations have provided evidence showing a strong associ-
ation between HLA-DRB1 and RA susceptibility and severi-
ty (4, 5). To date, however, there have been no meta-analyses
on other ethnic groups, especially for Asian-Mongoloid pop-
ulations. Individual studies have reported different results re-
garding the association of HLA alleles with RA. For example,
some have reported that the frequency of the HLA-DRB1
*0101 and *0401 alleles are significantly increased in RA
patients, whereas others have found no associations (6-9).
Therefore, we performed a meta-analysis on the association
between HLA and RA in Asian-Mongoloid population.
MATERIALS AND METHODS
Search strategy and inclusion criteria
We searched Pubmed and EMBase using the keywords
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Meta-analysis of the Association between HLA-DRB1 Allele and
Rheumatoid Arthritis Susceptibility in Asian Populations
The aims of this study were to summarize results on the association of HLA-DRB1
with rheumatoid arthritis (RA) in Asians and to determine if the shared epitope (SE)
hypothesis could explain the meta-analysis results. Among the papers published
between January 1987 and July 2006 on RA susceptibility in Asian-Mongoloid pop-
ulations (Korean, Japanese, Chinese, and Thai), 12 were selected for the meta-
analysis. Mongoloid-Asian patients with RA had significantly higher frequencies of
HLA-DRB1*0101, *0401, *0410, and *1001 than controls (OR 1.5-2.1, p<0.05 for
association). When analyses were restricted to more ethnically homogeneous pop-
ulations, HLA-DRB1*0405 showed a significant susceptibility to RA in Koreans (OR
5.65, 95% CI 4.32-7.39), whereas the HLA-DRB1*0301, *0403, *0406, *0701,
*1301, and *1405 alleles showed protective association with RA (OR 0.32-0.70,
p<0.05 for association). In conclusion, it was found that HLA-DRB1 *0101, *0401,
*0405, *0410, and *1001 are susceptible, while HLA-DRB1* 0301, *0403, *0406,
*0701, *1301, and *1405 are protective in Asian-Mongoloids. All the RA-associat-
ed alleles except DRB1*0301 could be explained by the structural model support-
ing the SE hypothesis that RA susceptibility is determined by the combination of
amino acid residues at HLA-DR  71 and  74, not by  71 alone.
Key Words : Arthritis, Rheumatoid; Genetics; Epitopes; HLA-DRB1; Meta-analysis; Asian Continental Ances-
try Group
Received : 16 January 2007
Accepted : 12 April 2007974 K.R. Jun, S.-E. Choi, C.-H. Cha, et al.
‘human leukocyte antigen’ and ‘rheumatoid arthritis’ for all
English language articles published between 1 January 1987
and 31 July 2006. The start time was based on the intro-
duction of molecular DRB1 typing in 1987 (10). We also
included studies referenced in any articles selected.
One reviewer evaluated the materials and methods section
of all identified articles, and selected only those that met all
the inclusion criteria as follows: 1) HLA-DRB1 alleles were
molecularly typed (high resolution level), 2) controls and
RA patients were Asian-Mongoloid populations, and 3) mate-
rials and methods were well-described and reliable. Although
assessment of study quality is considered important for sys-
tematic reviews and meta-analyses, scoring methods have
been considered problematic (11) and may not accurately
assess the quality measures of interest (12). Therefore, we
used reliability of patient selection, molecular typing method,
and statistical analysis method as quality variables.
HLA-DRB1 alleles were considered only when they were
typed in at least 2 independent studies. The frequency of
HLA-DRB1 alleles varies according to ethnic and racial back-
ground, with some alleles being extremely rare. Therefore,
articles were not required to identify all alleles for inclusion.
Statistical analysis
Comparisons of allele frequencies between patients and con-
trols were made using the Z test (13) and summary odds ratios
(ORs) with 95% confidence intervals (CIs). Summary ORs
were computed using fixed effects models of the Mantel-Haen-
szel method (13), and the heterogeneity of the study results
was evaluated with chi-square-based Q statistics. For the Man-
tel-Haenszel method, the test for heterogeneity is based on
the weights from the inverse-variance method (13). Consid-
ering the low power of the Q statistic, the heterogeneity test
was considered significant when the pvalue was less than 0.1
(14). Publication bias was assessed graphically by funnel plot
(15) and was statistically evaluated by the regression asym-
metry test (16), which has been shown to be a powerful test
for assessment of publication bias (17). Finally, the trim and
fill method was used to adjust for publication bias (18). All
analyses were performed using MedCalc for Windows, version
9.0 (MedCalc Software, Mariakerke, Belgium) and Compre-
hensive Meta Analysis V2 (Biostat, Englewood, NJ, U.S.A.).
HLA structure analysis
The radiography crystal structure of HLA-DRB1*0401
in complex with a peptide from human collagen II (PDB
entry 2SEB) was used as a structural template. The molecu-
lar modeling with energy minimization was carried out on
an OCTANE R1200 Silicon Graphics workstation with X-
build module of QUANTA software and Affinity module
of Insight II from Accerlys, Inc. Side chain conformations of
the modified residues were assigned to the preferred con-
former most similar to the conformation of the side chain in
the crystal structure templates and backbone conformations
were not changed under restraint. The qualities of the mod-
els were analyzed by PROCHECK (19).
RESULTS
Study characteristics included in this meta-analysis
A total of 5,234 articles were identified using the keywords
‘human leukocyte antigen’ and ‘rheumatoid arthritis’. After
Author
year (reference)
Ethnicity
Patients
No. 
(female %)
Mean age
(±SD or range)
Method
Controls
No. 
(female %)
Mean age
(±SD or range)
Lee et al. 2004 (6) Korean 574 (92%) 51 (±11.5) 392 (88%) 42 (±14.1) PCR-SSOP Sequencing
Kim et al. 1999 (20) Korean 90 (ND) ND 106 (ND) ND PCR-SSOP
Microsatellite typing
Hong et al. 1996 (21) Korean 61 (84%) 47 (19-68) 82 (ND) ND PCR-SSCP
Kim et al. 1995 (22) Korean 95 (93%) ND (20-62) 118 (ND) ND PCR-SSOP
Chan et al. 1994 (7) Chinese 70 (93%) ND (12-82) 80 (ND) ND PCR-SSOP
Molkentin et al. 1993 (23) Chinese 23 (65%) ND 21 (ND) ND Oligotyping
Seglias et al. 1992 (24) Chinese 66 (ND) ND 45 (ND) ND TaqI RFLP PCR-SSOP
Tokunaga et al. 1999 (8) Japanese 75 (ND) ND 493 (ND) ND PCR-SSOP
Takeuchi et al. 1996 (25) Japanese 96 (89%) 55.4 (±11.7) 96 (ND) ND PCR-SSCP
Yukioka et al. 1998 (9) Japanese 852 (81%) 60.4 (±12.0) 652 (ND) ND PCR-RFLP
Higami et al. 1997 (26) Japanese 82 (72%) ND 150 (ND) ND PCR-RFLP
Pimtanothai et al. 2002 (27) Thai 120 (90%) ND (22-77) 140 (ND) ND PCR-SSP Sequencing
Table 1. Characteristics of the studies included in the meta-analysis on the association of HLA-DRB1 with RA patients in Asian popu-
lations
RA, rheumatoid arthritis; ND, not described; PCR-SSOP, PCR-sequence-specific oligonucleotides probes; PCR-SSCP, PCR-single strand conforma-
tion polymorphism; PCR-SSP, PCR-sequence-specific primer; RFLP, restriction fragment length polymorphism.HLA-DRB1 and RA Susceptibility in Asian Populations 975
reviewing the abstracts, we selected 22 articles that studied
the association of HLA-DRB1 alleles with RA patients in
Asian populations. Ten of these articles were excluded from
the analysis: 2 were duplicate publications, 5 had only sero-
logic results, and 3 were studies in non-Mongoloid popula-
tions. Therefore, a total of 12 studies, which included 2,204
RA patients and 2,375 healthy controls, were used in our
meta-analysis (6-9, 20-27). Characteristics of the studies in-
cluded are presented in Table 1. All of 12 studies were report-
ing the association between HLA-DRB1 alleles and RA in
Asian-Mongoloid patients, including Korean, Japanese, Chi-
nese, and Thai individuals. The high-resolution typing for
HLA-DRB1 alleles was performed with adequately described
methods. All studies had a cross-sectional design.
Association of DRB1 alleles with RA susceptibility
A total of 30 alleles were assayed in the 12 studies: HLA-
DRB1*0101 (DR1); DRB1*1501, *1502, and *1602 (DR2);
HLA-DRB1*0301 (DR3); HLA-DRB1*0401, *0402,
*0403, *0404, *0405, *0406, *0407, *0408, and *0410
(DR4); DRB1*1101 and DRB1*1201 (DR5); DRB1*1301,
*1302 *1401, *1402, *1403, *1405, and *1406 (DR6);
HLA-DRB1*0701 (DR7); HLA-DRB1*0802 and *0803
(DR8); HLA-DRB1*0901 (DR9); and HLA-DRB1*1001
(DR10). The results of meta-analysis are summarized in Table
2, 3. The summary ORs showed that Asian-Mongoloid pati-
ents with RA had significantly higher frequencies of HLA-
DRB1*0101, *0401, *0410, and *1001 than controls (OR
1.5-2.1, p<0.05 for association). In contrast, the HLA-DRB1
*0301, *0403, *0406, *0701, *1301, and *1405 alleles
showed negative associations with RA (OR 0.32-0.70, p<
0.05 for association). Six of the 30 alleles (HLA-DRB1*0405,
*0802, *1202, *1302, *1403, and *1501) showed signifi-
cant heterogeneity (p<0.1 for heterogeneity). When the anal-
ysis was restricted to similar ethnic populations (i.e., the
Korean, Japanese, and Chinese cohorts), 2 of the alleles (HLA-
DRB1*0405 and *1403) no longer showed significant het-
erogeneity. In the case of the HLA-DRB1*0405 allele, how-
ever, a subgroup analysis of the 4 studies in Korean patients
showed a significant association with RA susceptibility (OR
5.65, 95% CI 4.32-7.39). Subanalysis of HLA-DRB1*1403
in Japanese patients also showed homogeneity, but the OR
was not significant (p=0.402 for association). 
The funnel plot to detect publication bias (15) showed
relatively symmetric for most alleles, except for HLA-DRB1*
1405 (not shown). Moreover, the regression asymmetry test
(16) did not reveal significant evidence for publication bias
(p<0.1), while studies on the HLA-DRB1*1405 allele still
showed significant publication bias (p=0.011).
Allele
Number of studies
(references)
Number of cases and controls
OR
(95% CI)
Case (n)
allele +/total
Control (n)
allele +/total
Test of null (2-tail)
Z-value p value*
Heterogeneity test 
Q-value p value
� df
Susceptible
0405 4 (only Korean)  5.650  362/820 84/698 12.676 0.000 1.579 3 0.664
(6, 20-22) (4.323-7.385)
0410 7 (6, 20-22, 25-27) 2.092 30/1,118 14/1,084 2.193  0.028  2.652  6  0.851 
(1082-4.047)
0401 12 (6-9, 20-27) 1.938 95/2,204 71/2,375 3.658  0.000  5.103  11  0.926
(1.359-2.761)
1001 4 (6-8, 24) 1.902 46/792 17/667 2.162 0.031 4.364 3 0.225
(1.062-3.407)
0101 6 (6-9, 24, 26) 1.523 250/1,719 215/1,812 3.828 0.000 5.093 5 0.405
(1.228-1.890)
Protective
1405 3 (6, 7, 26) 0.315 13/726 30/622 -3.405 0.001 1.802 2 0.406
(0.162-0.613)
1301 3 (6, 8, 26) 0.325 5/731 29/1,035 -2.394  0.017  3.565  2  0.168
(0.129-0.815)
0701 2 (6, 7) 0.379 40/644 69/472 -4.585 0.000 1.108 1 0.292
(0.250-0.574)
0301 2 (6, 7) 0.470 13/644 22/472 -2.045 0.041 0.993 1 0.319
(0.227-0.972)
0403 11 (6-8, 20-27) 0.505 38/1,352 120/1,723 -3.346 0.001 7.463 10 0.589
(0.338-0.754)
0406 10 (6-8, 20-23, 25-27) 0.704 78/1,286 154/1,678 -2.213 0.027 12.366 9 0.193
(0.516-0.961)
Table 2. Summary of cumulative meta-analysis for the association between HLA-DRB1 alleles and RA susceptibility in Asian popula-
tions
*p<0.05; 
� p<0.1. 976 K.R. Jun, S.-E. Choi, C.-H. Cha, et al.
Structural basis for RA susceptibility or protection
In the SE hypothesis of RA, the amino acid residue at DR
71 is critical for binding to the P4 position of the bound anti-
genic peptide, thus profoundly influencing T cell recogni-
tion and immune response. For example, a positively charged
residue (lysine or arginine) at position DR 71 can form a salt
bridge with a negatively charged residue (aspartate or gluta-
mate) at the P4 position. A modeling study of the MHC
class II-peptide-TCR interaction has shown that the CDR3
loop of TCR is likely to be in contact with the DR residue
71 and the P4 residue of the antigenic peptide (28-30). RA
susceptible alleles with a positively charged residue at 71 can
accommodate only an antigenic peptide with a negatively ch-
arged P4 residue, and the microenvironment of the salt bridge
between them can be optimally recognized by the CDR3 loop
of TCR, causing signaling immunocyte activation.
Based on the amino acid sequences of alleles identified as
susceptible or protective, however, it was suggested that RA
susceptibility is determined by the combination of two resi-
dues, 71 and 74, not by 71 alone. Although a positively char-
ged residue at 71 is of primary importance for RA suscepti-
bility of an allele, a residue at 74 cannot be ignored because
it can also be involved in the interaction with the P4 residue
Allele
Number of studies
(references)
Number of cases and controls
OR
(95% CI)
Case (n)
allele +/total
Control (n)
allele +/total
Test of null (2-tail)
Z-value p value*
Heterogeneity test 
Q-value p value
� df (Q)
No association
0402 4 (20, 21, 23, 24)  1.036 1/240 1/254 0.030 0.976 1.155 1 0.283
(0.105-10.192)
0404 11 (6, 7, 9, 20-27) 1.295 42/2,129 27/1,882 0.970  0.332  9.061  10  0.526
(0.768-2.183)
0407 6 (6, 20, 22, 25-27) 0.588 4/1,057 9/1,002 -0.957  0.339  2.062  5 0.841
(0.198-1.746)
0408 4 (6, 9, 20, 22) 0.631 2/1,611 4/1,268 -0.593  0.553  1.623  3  0.654
(0.138-2.892)
0802 5 (6-8, 25, 26) 0.587 29/897 108/1,211 -2.265  0.023  9.303  4 0.054
(0.370-0.931)
0803 5 (6-8, 25, 26) 0.757 96/897 220/1,211 -1.936  0.053  2.639  4  0.620
(0.571-1.004)
0901 4 (6-8, 26) 1.389 232/801 348/1,115 3.365  0.001  5.859  3  0.119 
(0.971-1.987)
1101 4 (6-8, 26) 0.641 47/801 99/1,115 -2.469  0.014  3.850  3  0.278
(0.407-1.011)
1106 2 (6, 7) 1.891 3/644 1/472 0.607  0.544  0.271  1  0.602
(0.242-14.768)
1201 4 (6-8, 26) 1.063 72/801 118/1,115 0.354  0.724  2.249  3  0.522
(0.756-1.496)
1202 3 (6, 7, 26) 0.709 42/726 49/622 -1.520  0.128  5.067  2  0.079
(0.456-1.104)
1302 3 (6, 7, 26) 0.356 59/731 230/1,035 -5.943  0.000  4.783  2  0.091
(0.253-0.500)
1401 3 (6, 7, 26) 0.686 25/726 33/622 -1.351  0.177  0.087  2  0.957
(0.397-1.185)
1402 2 (6, 8) 1.754 4/649 9/885 0.797  0.425  0.235  1  0.628
(0.440-6.988)
1403 3 (6, 8, 26) 0.733  13/731 44/1,035 -0.925  0.355  7.673  2  0.022
(0.380-1.415)
1406 3 (6, 7, 26) 0.978  10/726 11/622 -0.047  0.963  1.337  2  0.512
(0.384-2.490)
1501 4 (6-8, 26)  1.013 121/801 221/1,115 0.094  0.925  19.509  3  0.000 
(0.774-1.325)
1502 5 (6-9, 26) 1.093 221/1,653 313/1,767 0.818  0.413  2.906  4  0.574
(0.884-1.351)
1602 3 (6, 7, 26) 0.931 20/726 19/622 -0.218  0.827  0.536  2  0.765 
(0.487-1.777)
Table 3. Summary of cumulative meta-analysis for the association between HLA-DRB1 alleles and RA susceptibility in Asian popula-
tions
*p<0.05; 
� p<0.1. (Fig. 1A). In RA-susceptible alleles such as DRB1*0101,
0401, 0405, 0410, and 1001 (Fig. 1B, C), the residue 71 is
positively charged and forms a salt bridge with the negative-
ly charged residue P4, while the alanine residue at 74 does
not affect this DR 71-P4 interaction due to its small size. In
the DRB1*0403, 0406, and 1405 alleles (Fig. 1D), however,
a negatively charged residue, glutamate, at position 74 repels
the P4 residue by electrostatic repulsion, resulting in the abil-
ity to form the DR 71-P4 salt bridge. This would lead to mis-
alignment of the antigenic peptide in the binding groove and
impair antigen recognition by TCR, making these alleles pro-
tective against RA. In the DRB1*0701 allele (Fig. 1E), the
position of glutamine at 74 would be determined by a hydro-
gen bond between the N atom of the side chain of Q74 and
the backbone carbonyl oxygen of the 70 residue. Therefore,
the partial negative charge on the O atom of the side chain
of Q74 would face an acidic P4 residue, preventing the for-
mation of the DR 71-P4 salt bridge by electrostatic repulsion.
In the DRB1*1301 allele (Fig. 1F), 71 is negatively charged
and therefore cannot form a salt bridge with an acidic residue
at P4. Taken together, these findings indicate that a positively
charged residue at 71 is a necessary but not sufficient condition
for RA susceptibility, because the residue at 74 can affect the
formation of the DR 71-P4 salt bridge. 
DISCUSSION
HLA molecules with specific shared epitopes (SEs) are con-
sidered to explain about 30-40% of the genetic risk for RA
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Fig. 1. Structural analysis of the interactions between the P4 residue of the antigenic peptide and the residues at positions 71 and 74 of DR
in RA susceptible and protective alleles. (A) Overall structure of the HLA-DR molecule containing a peptide with a negatively charged residue
at P4. The positions of DR residues 71-74 are indicated by red labels. The region inside the blue rectangle is magnified in panels B-F. (B)
Close-up of the interaction of the P4 residue with the HLA DRB1*0401 molecule. Lysine at position 71 makes a salt bridge with the negatively
charged P4 residue, leading to the optimal binding of an antigenic peptide for TCR recognition. A small residue, alanine, at amino acid 74
does not inhibit the salt bridge of DR 71-P4. The residues at positions 72 and 73 are not involved in peptide binding. (C) Close-up of the
interaction of the P4 residue with HLA DRB1*0101, 0404, 0405, 0410, and 1001. The microenvironment is similar to that of DRB1*0401 due
to the similar properties of arginine and lysine. (D) Close-up of the interaction of the P4 residue with HLA DRB1* 0403, 0406, and 1405. A
negatively charged residue, glutamate, at position 74 would repel the negatively charged P4 residue and inhibit formation of the DR 71-P4
salt bridge. (E) Close-up of the interaction of the P4 residue with HLA DRB1*0701. The hydrogen bond between the N atom of the side chain
of Q74 and the backbone carbonyl oxygen of the  70 residue causes an electrostatic repulsion between the partial negative charge on the
O atom of the side chain of Q74 and an acidic P4 residue. (F) Close-up of the interaction of the P4 residue with HLA DRB1*1301.
A
D
B
E
C
F Protective
Susceptible
Protective
Susceptible
Protective(31). There are 5 major susceptibility alleles that share the
epitopes QKRAA or QRRAA between residues 70 and 74
of HLA-DRB1: DRB1*0401, *0404, *0101, *0405, and
*1402. Although these SE susceptibility sequences increase
the risk for RA, there is some heterogeneity in the relative
contribution of these 5 alleles to RA susceptibility. In popu-
lations in which DRB1*0401 and DRB1*0404 are com-
mon, these alleles are usually more associated with the dis-
ease than others. Conversely, in populations in which DRB1
*0401 and DRB1*0404 are rare, other alleles, such as DRB1
*0405 and DRB1*1402, account for the HLA-associated
disease risk. 
Our meta-analysis of Asian-Mongoloid populations show-
ed that patients with RA had higher frequencies of HLA-
DRB1*0101, *0401, *0405, *0410, and *1001 than con-
trols. Unlike in Caucasian populations (5, 32), however, the
HLA-DRB1*0404 and *1402 alleles did not increase the
susceptibility to RA in Asian-Mongoloid populations. The
lack of association between these alleles, which have the same
epitope as HLA-DRB1*0405, and RA may be a reflection
of the low frequency of these alleles in Asian populations (33).
Our meta-analysis also showed that certain DRB1 alleles
(HLA-DRB1*0301, *0403, *0406, *0701, *1101, *1301,
and *1405) occur at lower frequencies in RA patients than in
controls, suggesting that they have protective effects. The
protective alleles identified in Asian patients also differed from
those reported in Caucasians (HLA-DRB1*07, *1201, *1301,
and *1501) (3). 
Our structural model can explain the role of SE for most
of the alleles showing significant RA susceptibility or pro-
tection, except for the protective role of DRB1*0301 allele.
Since HLA-DRB1*0301 has been reported to be suscepti-
ble to other autoimmune diseases such as autoimmune hep-
atitis (34, 35) and our results on this allele were obtained
from only 2 papers, we extended the meta-analysis using
papers with low resolution results for DRB1*03. This was
justified with the fact that a great majority of Asian-Mongo-
loid individuals with HLA-DRB1*03 are positive for *0301
(33). The result showed that HLA-DRB1*03 was significant-
ly less frequent in RA patients than in controls, although none
of the individual studies showed a statistically significunt dif-
ference (Table 4). HLA-DRB1*0301 allele has been report-
ed to be marginally protective in Singaporean Chinese, al-
though the statistical significance was lost after Bonferroni
correction (7). The marginal association of DRB1*0301 with
RA protection may arise from loose linkage disequilibrium
with other genetic loci near to HLA. Genome scan analysis has
revealed that genetic associations with RA are complex and
that at least two additional genetic effects are present close to
or within the major histocompatibility complex (36, 37). The
A9 allele of the MICA gene, located between class I and class
II HLA, has been found to be protective against RA in Koreans
(38). Our unpublished data on MICA-DRB1 haplotype dis-
tribution showed strong linkage disequilibrium between the
DRB1*0301 and MICA A9 alleles in Koreans (relative link-
age disequilibrium=0.633), suggesting that susceptibility of
HLA-DRB*0301 to RA may be due to other nearby genet-
ic loci in linkage disequilibrium.
Our analysis showed that the DRB1*0405, *0410, and
*0401 alleles are associated with RA susceptibility whereas
the DRB1*0403 and DRB1*0406 alleles are associated with
RA protection in Asian-Mongoloid individuals. Among the
HLA-DR antigens, HLA-DR4 is the most heterogeneous
in Asian populations and the DRB1*0403 and *0406 alle-
les are more frequently present in normal Koreans (33, 39)
and Japanese (33, 40) than in Caucasians (less than 0.1%)
(33, 41). This may be the reason why several studies have
reported a lack of association between the DR4 antigen and
RA in Asians. 
In conclusion, our meta-analysis enabled us to identify the
HLA-DRB1 alleles associated with susceptibility to RA in
Asian populations. Our structural model supporting SE hy-
pothesis indicated that RA susceptibility is determined by
the combination of the residues at 71 and 74, not by 71 alone,
for all associated alleles except DRB1*0301. The weak asso-
ciation between DRB1*0301 and RA may arise from link-
age disequilibrium with nearby susceptible loci. This analy-
sis will provide a basis for further studies concerning the effect
of HLA-DRB1 and nearby loci on RA in Asian populations.
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